Results 21 to 30 of about 1,321,964 (375)

Ranking of Administrative Districts of Almaty City by Incidence of Hepatitis B and C [PDF]

open access: yesInternational Journal of Biomedicine, 2017
The incidence of acute and chronic hepatitis B and C in the districts of Almaty city over the past 10 years is presented in this article.
Lyazat Zh. Orakbay   +3 more
doaj   +1 more source

Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism [PDF]

open access: yes, 2003
Background. Tumor necrosis factor-alpha (TNF-alpha) is involved in the pathogenesis of chronic active hepatitis C. Polymorphisms in the promoter region of the TNF-alpha gene can alter the TNF-alpha expression and modify the host immune response.
Folwaczny, Christian   +8 more
core   +1 more source

Lipoprotein Receptors and Lipid Enzymes in Hepatitis C Virus Entry and Early Steps of Infection

open access: yesScientifica, 2012
Viruses are obligate intracellular agents that depend on host cells for successful propagation, hijacking cellular machineries to their own profit. The molecular interplay between host factors and invading viruses is a continuous coevolutionary process ...
Eve-Isabelle Pécheur
doaj   +1 more source

Raised serum transaminases during treatment with pegylated interferon for chronic hepatiti C [PDF]

open access: yes, 2016
Introduction : Serum transaminases rose significantly in 7 patients with chronic hepatitis C, genotypes 2 and 3, who were treated with pegylated interferon and ribavirin. Methods : 219 patients with chronic hepatitis C, genotypes 2 and 3, were treated
Datta, S.   +3 more
core   +1 more source

The Relationship Between Hepatic Activity Index and Serum Tumor Necrosis Factor Alpha Levels in Patients with Chronic Active Hepatitis-B and Chronic Active Hepatitis-C

open access: yesMedicine Science, 2015
In the present study, we investigated the relationship between serum TNF-α levels and hepatic activity in liver biopsies of chronic hepatitis B and C patients.The study was performed on 30 chronic hepatitis B patients, 25 chronic hepatitis C ...
Yilmaz Bilgic   +8 more
doaj   +1 more source

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy [PDF]

open access: yes, 2006
BACKGROUND: The epidemiology of acute hepatitis C has changed during the past decade in Western countries. Acute HCV infection has a high rate of chronicity, but it is unclear when patients with acute infection should be treated.
Ancarani, Fausto   +14 more
core   +1 more source

Thyroid Diseases and Hepatitis C Chronic Infection

open access: yes, 2015
More than 185 million subjects worldwide are infected by Hepatitis C virus (HCV), and about 20% of patients chronically infected with HCV progress to cirrhosis and 1-2% to hepatocarcinoma [1].
Aless, R. Antonelli
semanticscholar   +1 more source

Telaprevir for previously untreated chronic hepatitis C virus infection.

open access: yesNew England Journal of Medicine, 2011
BACKGROUND In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, has shown improved efficacy, with potential for shortening the
I. Jacobson   +23 more
semanticscholar   +1 more source

Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C [PDF]

open access: yes, 1999
BACKGROUND/AIMS: Oxidative stress could play a role in the pathogenesis of hepatitis C virus infection. We investigated the oxidant/antioxidant status in peripheral blood mononuclear cells from patients with chronic hepatitis C and controls.
Beloqui, O. (Óscar)   +7 more
core   +1 more source

Treatment of Chronic Hepatitis C with High Dose Interferon Therapy Experience From Pertamina Central Hospital Jakarta [PDF]

open access: yes, 2002
Background: Until several years ago, interferon alfa was the only drug with proven benefit for the treatment of chronic Hepatitis C. Several therapy categories such as fixed-dose regimens, induction-dose regimens and escalation-dose regimens are already ...
Simanjuntak, W. (Waldemar)
core   +1 more source

Home - About - Disclaimer - Privacy